Target Details
| UniProt AC | P10415 |
|---|---|
| Gene Symbol | BCL2 |
| Protein Name | Apoptosis regulator Bcl-2 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00452 (Bcl-2) PF02180 (BH4) |
Summary
- Multi-target molecules 1,065
- Clinical molecules 0
- Avg pChEMBL 8.33
KEGG Pathways (43)
- AGE-RAGE signaling pathway in diabetic complications
- Adrenergic signaling in cardiomyocytes
- Amyotrophic lateral sclerosis
- Apoptosis
- Apoptosis - multiple species
- Autophagy - animal
- Chemical carcinogenesis - receptor activation
- Cholinergic synapse
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Epstein-Barr virus infection
- Estrogen signaling pathway
- Fluid shear stress and atherosclerosis
- Focal adhesion
- Gastric cancer
- HIF-1 signaling pathway
- Hedgehog signaling pathway
- Hepatitis B
- Herpes simplex virus 1 infection
- Human immunodeficiency virus 1 infection
- JAK-STAT signaling pathway
- Lipid and atherosclerosis
- Measles
- MicroRNAs in cancer
- NF-kappa B signaling pathway
- NOD-like receptor signaling pathway
- Necroptosis
- Neurotrophin signaling pathway
- PI3K-Akt signaling pathway
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Platinum drug resistance
- Prostate cancer
- Protein processing in endoplasmic reticulum
- Salmonella infection
- Shigellosis
- Small cell lung cancer
- Sphingolipid signaling pathway
- Toxoplasmosis
- Tuberculosis
- p53 signaling pathway
Associated Diseases (8)
Active Molecules (1,065)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
FZNKVMJEKKNRAB
|
10.2 | Ki | 2 | — | |
OHTSOHPEJKZMRQ
|
10.2 | Ki | 2 | — | |
GHGYXKOMFUVEJU
|
10.2 | IC50 | 2 | — | |
SIJQUKCDTKDEJY
|
10.2 | IC50 | 2 | — | |
ZOJIZJLLXHJEOU
|
10.2 | IC50 | 2 | — | |
CBAIHQVISAQWRA
|
10.2 | IC50 | 2 | — | |
KRIYPLQRPPASMS
|
10.2 | Ki | 2 | — | |
TXHANOMNIAFKRC
|
10.2 | Ki | 2 | — | |
OZHFDEICXXASII
|
10.2 | IC50 | 2 | — | |
GHGYXKOMFUVEJU
|
10.2 | IC50 | 2 | — | |
GYTVXYQYYCDNGK
|
10.2 | Ki | 2 | — | |
INVLADIWFNLIJA
|
10.2 | Ki | 2 | — | |
UVWRVKWIBRSQJS
|
10.2 | Ki | 2 | — | |
ZOCXBGYQWZTRCP
|
10.2 | IC50 | 2 | — | |
ZZJFOLVRBJKZDX
|
10.2 | Ki | 2 | — | |
ZQTKOYMWCCSKON
|
10.1 | IC50 | 2 | — | |
KYCGDQCURKVJHT
|
10.1 | IC50 | 2 | — | |
MEGYMYFGAZFZKU
|
10.1 | IC50 | 2 | — | |
JQQLQJPCXNPDNY
|
10.1 | IC50 | 2 | — | |
AJEHGEIYNMQGAS
|
10.1 | Ki | 2 | — | |
FILCHOLUTJMNBJ
|
10.1 | Ki | 2 | — | |
LWCSKJIMSRNBDV
|
10.1 | Ki | 2 | — | |
SVCWQWYNSWVDFU
|
10.1 | Ki | 2 | — | |
XFFVXKYJLBFFMJ
|
10.1 | Ki | 2 | — | |
CBYFMYJFHHCCEW
|
10.1 | Ki | 2 | — | |
DDTZNAGFGJQFDX
|
10.1 | IC50 | 2 | — | |
ZEICJNVOHKUFOK
|
10.1 | IC50 | 2 | — | |
FIZCAKIZMHKRLU
|
10.1 | Ki | 2 | — | |
YHZRYTLQEKOKAC
|
10.1 | Ki | 2 | — | |
YHZRYTLQEKOKAC
|
10.1 | Ki | 2 | — | |
CDWJOJMXGYYZLV
|
10.1 | IC50 | 2 | — | |
PJXASAHBKOYFLH
|
10.1 | IC50 | 2 | — | |
AHBWODOOZLINCZ
|
10.1 | Ki | 2 | — | |
ANXHQFQNTBOWSJ
|
10.1 | Ki | 2 | — | |
ANXHQFQNTBOWSJ
|
10.1 | Ki | 2 | — | |
AWSJKVCJFFTDQR
|
10.1 | Ki | 2 | — | |
FEHADDFZBPXETF
|
10.1 | Ki | 2 | — | |
MGWXLLVQWQNLFI
|
10.1 | Ki | 2 | — | |
PAUBCWVLFKEYKC
|
10.1 | Ki | 2 | — | |
QOCBEKUXIFDWRQ
|
10.1 | Ki | 2 | — | |
QPAZAGHFQBJAEC
|
10.1 | Ki | 2 | — | |
QVGLQQZZLZAUTO
|
10.1 | Ki | 2 | — | |
YCDWKHUBQITHAW
|
10.1 | Ki | 2 | — | |
YCDWKHUBQITHAW
|
10.1 | Ki | 2 | — | |
ZQYRKYJEVJEHPJ
|
10.1 | Ki | 2 | — | |
VIDAGZSPHIUJEB
|
10.0 | IC50 | 2 | — | |
YLEOZLQKJRFKIA
|
10.0 | IC50 | 2 | — | |
USONJWHLSCGZAX
|
10.0 | IC50 | 2 | — | |
ARPCRJCCFGFGSC
|
10.0 | IC50 | 2 | — | |
ZOJIZJLLXHJEOU
|
10.0 | IC50 | 2 | — |